Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Altimmune, Inc. ALT

Set alert

Price alert · ALT

All alert types
2.08 USD +0.06 +2.72%

As of Nov 3, 1:09 PM ET

Bid
2.07 × 2
Ask
2.08 × 2
2.03 Day range 2.08
1.99 52-week range 6.44
YTD
-42.52%
1 year
-47.60%
Open
2.04
Prev close
2.02
Mkt cap
403.62M
Vol
875.33K
Avg vol
4.01M
EPS
-0.76
P/E
0.00
Div yield
0.00%
More statistics
Low
2.03
High
2.08
Forward P/E
-5.14
Beta
0.07
Short ratio
5.81
Inst. own
56.68%
Dividend
0.00
Ex-div date
Jan 19, 2017
50-d avg
7.91
200-d avg
7.41
1y target
22.86

MAX chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Nov 7, 2023Earnings: -0.39; estimate -0.4; surprise 2.5%
Signals (35)
NameDateAgo
MACD: Sell SignalMar 1, 20268 months ago
SMA: BearishFeb 1, 20269 months ago
SMA: BullishJan 1, 202610 months ago
MACD: Buy SignalJan 1, 202610 months ago
SMA: BearishDec 1, 202511 months ago
SMA: BullishNov 1, 20251 year ago
MACD: Sell SignalApr 1, 20251 year ago
SMA: BearishDec 1, 20241 year ago
SMA: BearishDec 1, 20241 year ago
SMA: BullishNov 1, 20242 years ago
SMA: BullishNov 1, 20242 years ago
SMA: BearishJun 1, 20242 years ago
SMA: BearishApr 1, 20242 years ago
SMA: BullishDec 1, 20232 years ago
SMA: BullishDec 1, 20232 years ago
MACD: Buy SignalDec 1, 20232 years ago
SMA: BearishMar 1, 20233 years ago
MACD: Sell SignalMar 1, 20233 years ago
SMA: BearishFeb 1, 20233 years ago
SMA: BullishDec 1, 20223 years ago

Newest 20 of 35.

Analyst view

Consensus: buy

Buy
Price target (mean) 22.86 +1001.5% upside
Target (low)
12.00
Target (mean)
22.86
Target (high)
28.00
Ratings (0m) 8 7 buy · 1 hold · 0 sell
  • Strong buy3
  • Buy4
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 8
  • 1 month ago 9
  • 2 months ago 8
  • 3 months ago 8

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ALT analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.24-0.39 – 3.02-0.3289+173.0%0-100.0%6
Next quarter-0.33667-0.35 – -0.32-0.34+1.0%1.00K-80.0%5
Current year-0.80333-1.40 – 1.96-1.43+43.7%3.57K-99.2%6
Next year-1.09-1.97 – 0.73-0.80333-36.1%28.57M+800300.2%6

Upgrades and downgrades

The latest rating changes

ALT analyst upgrades and downgrades
DateFirmActionFromTo
Nov 14, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 12, 2024UBSInitiated—Buy
Aug 12, 2024B. Riley SecuritiesReiteratedBuyBuy
Jun 25, 2024B. Riley SecuritiesReiteratedBuyBuy
Jun 21, 2024Piper SandlerMaintainedOverweightOverweight
May 14, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 10, 2024JMP SecuritiesMaintainedMarket OutperformMarket Outperform
Apr 29, 2024GuggenheimDowngradeBuyNeutral
Apr 1, 2024HC Wainwright & Co.MaintainedBuyBuy
Mar 28, 2024B. Riley SecuritiesReiteratedBuyBuy
Feb 13, 2024B. Riley SecuritiesMaintainedBuyBuy
Dec 1, 2023HC Wainwright & Co.ReiteratedBuyBuy
Nov 9, 2023B. Riley SecuritiesMaintainedBuyBuy
Aug 14, 2023HC Wainwright & Co.MaintainedBuyBuy
Aug 11, 2023B. Riley SecuritiesMaintainedBuyBuy
Jul 12, 2023JMP SecuritiesReiteratedMarket OutperformMarket Outperform
May 15, 2023HC Wainwright & Co.ReiteratedBuyBuy
Mar 31, 2023JMP SecuritiesReiterated—Market Outperform
Mar 22, 2023JMP SecuritiesReiterated—Market Outperform
Mar 22, 2023Goldman SachsDowngradeBuyNeutral
Mar 9, 2023HC Wainwright & Co.Reiterated—Buy
Feb 6, 2023JMP SecuritiesReiterated—Market Outperform
Jan 20, 2023HC Wainwright & Co.Reiterated—Buy
Jan 18, 2023Evercore ISI GroupMaintained—Outperform
Dec 1, 2022Goldman SachsInitiated—Buy
Nov 11, 2022JMP SecuritiesMaintained—Market Outperform
Sep 16, 2022GuggenheimMaintained—Buy
Aug 31, 2022JefferiesMaintained—Buy
Aug 17, 2022HC Wainwright & Co.Maintained—Buy
Aug 12, 2022B. Riley SecuritiesMaintained—Buy